# Effects of Neuromuscular Block Reversal With Sugammadex vs Neostigmine on Postoperative Respiratory Outcomes After Major Abdominal Surgery

> **NCT02361060** · PHASE4 · COMPLETED · sponsor: **Enrique Alday Muñoz** · enrollment: 130 (actual)

## Conditions studied

- Major Abdominal Surgery

## Interventions

- **DRUG:** Neostigmine
- **DRUG:** Sugammadex
- **DRUG:** Atropine

## Key facts

- **NCT ID:** NCT02361060
- **Lead sponsor:** Enrique Alday Muñoz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-07-04
- **Final completion:** 2016-07-04
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02361060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02361060, "Effects of Neuromuscular Block Reversal With Sugammadex vs Neostigmine on Postoperative Respiratory Outcomes After Major Abdominal Surgery". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02361060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*